{"id":"https://openalex.org/W2007150880","doi":"https://doi.org/10.1158/1538-7445.tumimm2012-b72","title":"Abstract B72: CD8\u03b1\u03b1+ langerin+ dendritic cells maintain the effector CD8 T cell population after adoptive transfer.","display_name":"Abstract B72: CD8\u03b1\u03b1+ langerin+ dendritic cells maintain the effector CD8 T cell population after adoptive transfer.","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W2007150880","doi":"https://doi.org/10.1158/1538-7445.tumimm2012-b72","mag":"2007150880"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.tumimm2012-b72","doi":"https://doi.org/10.1158/1538-7445.tumimm2012-b72","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.tumimm2012-b72","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"John David Gibbins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200359443","display_name":"Malaghan Institute of Medical Research","ror":"https://ror.org/02487ts63","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I200359443"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"John David Gibbins","raw_affiliation_strings":["Malaghan Institute of Medical Research, Wellington, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Malaghan Institute of Medical Research, Wellington, New Zealand","institution_ids":["https://openalex.org/I200359443"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014939316","display_name":"Ian F. Hermans","orcid":"https://orcid.org/0000-0002-7584-887X","observed_orcids":["https://orcid.org/0000-0002-7584-887X"]},"institutions":[{"id":"https://openalex.org/I200359443","display_name":"Malaghan Institute of Medical Research","ror":"https://ror.org/02487ts63","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I200359443"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Ian Hermans","raw_affiliation_strings":["Malaghan Institute of Medical Research, Wellington, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Malaghan Institute of Medical Research, Wellington, New Zealand","institution_ids":["https://openalex.org/I200359443"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090655217","display_name":"Troels R. Petersen","orcid":"https://orcid.org/0000-0002-6378-352X","observed_orcids":["https://orcid.org/0000-0002-6378-352X"]},"institutions":[{"id":"https://openalex.org/I200359443","display_name":"Malaghan Institute of Medical Research","ror":"https://ror.org/02487ts63","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I200359443"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Troels Petersen","raw_affiliation_strings":["Malaghan Institute of Medical Research, Wellington, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Malaghan Institute of Medical Research, Wellington, New Zealand","institution_ids":["https://openalex.org/I200359443"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I200359443"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"73","issue":"1_Supplement","first_page":"B72","last_page":"B72"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/langerin","display_name":"Langerin","score":0.828000009059906},{"id":"https://openalex.org/keywords/cd207","display_name":"CD207","score":0.8100000023841858},{"id":"https://openalex.org/keywords/adoptive-t-cell-therapy","display_name":"adoptive T cell therapy","score":0.8560000061988831},{"id":"https://openalex.org/keywords/effector-cd8-t-cells","display_name":"CD8+ effector T cells","score":0.8989999890327454},{"id":"https://openalex.org/keywords/t-cell-survival","display_name":"T cell survival","score":0.722000002861023},{"id":"https://openalex.org/keywords/cross-presentation","display_name":"cross-presentation","score":0.8309999704360962},{"id":"https://openalex.org/keywords/antigen-presentation","display_name":"antigen presentation","score":0.7390000224113464}],"concepts":[{"id":"https://openalex.org/C119765067","wikidata":"https://www.wikidata.org/wiki/Q6485957","display_name":"Langerin","level":4,"score":0.7378300428390503},{"id":"https://openalex.org/C90375314","wikidata":"https://www.wikidata.org/wiki/Q3537484","display_name":"Adoptive cell transfer","level":4,"score":0.614661693572998},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5673404932022095},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5656921863555908},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5571350455284119},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5499028563499451},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5216858386993408},{"id":"https://openalex.org/C67662055","wikidata":"https://www.wikidata.org/wiki/Q1047791","display_name":"Antigen-presenting cell","level":4,"score":0.4797897934913635},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.46537846326828003},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.43158280849456787},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.42136508226394653},{"id":"https://openalex.org/C2778170410","wikidata":"https://www.wikidata.org/wiki/Q506253","display_name":"Dendritic cell","level":3,"score":0.4091002345085144},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.34128719568252563},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1989297866821289},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.143572598695755},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.tumimm2012-b72","doi":"https://doi.org/10.1158/1538-7445.tumimm2012-b72","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.tumimm2012-b72","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1502650521","https://openalex.org/W1266065098","https://openalex.org/W2105050889","https://openalex.org/W2096953466","https://openalex.org/W2002481712","https://openalex.org/W4200261977","https://openalex.org/W2152040063","https://openalex.org/W2012660279","https://openalex.org/W2327204815","https://openalex.org/W4398221229"],"abstract_inverted_index":{"Abstract":[0],"Adoptive":[1],"cell":[2,268,282,349,428],"transfer":[3],"(ACT)":[4],"is":[5,63,89,106,174,183,194],"a":[6,22,48,90,143,161,309,370,401],"promising":[7],"new":[8],"area":[9],"of":[10,18,28,37,50,56,69,82,96,101,111,135,145,180,219,250,257,312,336,376,395,407,436],"anti-cancer":[11],"therapy.":[12,409],"The":[13,99],"process":[14,46,128],"involves":[15],"the":[16,29,38,43,67,70,94,97,109,133,149,153,177,181,191,203,215,227,255,258,265,280,392,405,424,437],"isolation":[17],"T":[19,30,53,104,137,167,224,267,281,293,296,314,348,379,427],"cells":[20,31,40,54,72,105,113,168,189,225,243,294,315,380,422],"from":[21,190],"patient's":[23],"blood,":[24,192],"in":[25,75,176,201,226,239,246,263,288,346,355,372,384],"vitro":[26,289],"stimulation":[27,134],"against":[32,387],"cancer":[33,60],"antigens,":[34],"then":[35],"re-infusion":[36],"activated":[39,290],"back":[41],"into":[42,320],"patient.":[44],"This":[45,171],"provides":[47],"population":[49,269,311,429],"effector":[51,222,425],"CD8":[52,103,136,166,223,266,292,378,426],"capable":[55],"recognizing":[57],"and":[58,84,117,152,193,217,285,351,448],"killing":[59],"cells.":[61,138],"ACT":[62,408],"currently":[64],"limited":[65],"by":[66,169,365],"ability":[68,110,163],"transferred":[71,221,287,319,377],"to":[73,92,115,164,196,253,327,403],"survive":[74],"high":[76,374],"numbers":[77,375],"for":[78,132,205],"an":[79,198,321],"extended":[80],"period":[81],"time":[83],"therefore":[85,208,360],"overcoming":[86],"this":[87,230,273,344,396],"problem":[88],"focus":[91],"improve":[93],"efficacy":[95,406],"treatment.":[98],"activation":[100],"cancer-specific":[102],"dependent":[107],"on":[108,121,441],"dendritic":[112,421],"(DCs)":[114],"acquire":[116],"present":[118],"exogenous":[119],"antigens":[120],"major":[122],"histocompatibility":[123],"complex":[124],"class":[125],"I":[126],"(a":[127],"known":[129],"as":[130],"cross-presentation)":[131],"We":[139,207,307],"have":[140,160,233],"previously":[141],"found":[142,175,308],"subset":[144,173,262,398],"splenic":[146],"DCs":[147,213,340,368],"expressing":[148],"CD8\u03b1\u03b1":[150],"homodimer":[151],"c-type":[154],"lectin":[155],"receptor":[156,237],"langerin":[157],"(CD207),":[158],"that":[159,210,333,362,390],"strong":[162],"activate":[165],"cross-presentation.":[170],"DC":[172,261,397],"marginal":[178],"zone":[179],"spleen,":[182],"highly":[184],"efficient":[185],"at":[186],"phagocytosing":[187],"apoptotic":[188],"believed":[195],"play":[197,369],"important":[199],"role":[200,256,371],"scanning":[202],"blood":[204],"antigens.":[206],"hypothesized":[209],"CD8\u03b1\u03b1+":[211,259,338,366,419],"langerin+":[212,260,339,367,420],"influence":[214],"survival":[216],"expansion":[218],"adoptively":[220,286],"blood.":[228],"Within":[229],"project":[231],"we":[232,275],"used":[234],"langerin-diphtheria":[235],"toxin":[236],"mice,":[238],"which":[240],"all":[241],"langerin-expressing":[242],"are":[244],"ablated":[245],"vivo":[247],"upon":[248],"injection":[249],"diphtheria":[251],"toxin,":[252],"address":[254],"maintaining":[264],"after":[270,381,430],"ACT.":[271],"For":[272],"purpose,":[274],"challenged":[276],"mice":[277,328,332],"intravenously":[278],"with":[279,301],"thymoma":[283],"EG7.OVA":[284,322],"OVA-specific":[291],"(OT-I":[295],"cells)":[297],"12":[298],"days":[299],"later":[300],"or":[302],"without":[303,329],"prior":[304],"langerin-DC":[305],"depletion.":[306],"larger":[310],"OT-I":[313,347],"when":[316,325],"these":[317],"were":[318,334],"bearing":[323],"host":[324],"compared":[326],"tumors.":[330],"Interestingly,":[331],"depleted":[335],"their":[337,352],"did":[341],"not":[342],"develop":[343],"increase":[345,391,404],"number":[350],"absence":[353],"resulted":[354],"reduced":[356],"survival.":[357],"Our":[358],"data":[359],"suggest":[361],"antigen":[363],"presentation":[364],"sustaining":[373],"ACT,":[382],"resulting":[383],"increased":[385],"protection":[386],"EG7.OVA.":[388],"Manipulations":[389],"stimulatory":[393],"capacity":[394],"could":[399],"be":[400],"way":[402],"Citation":[410],"Format:":[411],"John":[412],"David":[413],"Gibbins,":[414],"Ian":[415],"Hermans,":[416],"Troels":[417],"Petersen.":[418],"maintain":[423],"adoptive":[431],"transfer.":[432],"[abstract].":[433],"In:":[434],"Proceedings":[435],"AACR":[438],"Special":[439],"Conference":[440],"Tumor":[442],"Immunology:":[443],"Multidisciplinary":[444],"Science":[445],"Driving":[446],"Basic":[447],"Clinical":[449],"Advances;":[450],"Dec":[451],"2-5,":[452],"2012;":[453],"Miami,":[454],"FL.":[455],"Philadelphia":[456],"(PA):":[457],"AACR;":[458],"Cancer":[459],"Res":[460],"2013;73(1":[461],"Suppl):Abstract":[462],"nr":[463],"B72.":[464]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}